Intelligent DNA Nanosystem for Broad-Spectrum Oncological Typing and Therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Multiple primary cancers require advanced diagnostic and therapeutic solutions.
• Existing treatments often lack cancer-targeting selectivity and broad-spectrum efficacy.
• Need for precise differentiation and treatment of heterogeneous cancer types.

Purpose of the Study:

• To develop a quadruple-input-triggered OR-AND-AND logic gated oncological nanosystem (OAA).
• To achieve precise cancer cell differentiation and targeted therapy using a logic-gated approach.
• To integrate photodynamic therapy (PDT) and gene silencing for synergistic cancer treatment.

Main Methods:

• Utilized four cancer-related markers (EpCAM, MUC1, APE1, miR-21) for signal generation.
• Developed an OR-AND-AND logic gating mechanism for cancer-specific activation.
• Integrated PDT and gene silencing (miR-21, VEGFR2 mRNA) into the nanosystem.

Main Results:

• OAA system precisely differentiated cancer cell lines (MCF-7, HepG2, HeLa) from normal cells (MCF-10A) using fluorescence signals.
• Achieved cancer-specific activation of Ce6 release, miR-21, and VEGFR2 mRNA gene silencing.
• Demonstrated significant apoptosis in multiple cancer cell lines with minimal impact on normal cells.

Conclusions:

• The OAA nanosystem offers enhanced cancer-targeting specificity and broad-spectrum therapeutic versatility.
• This intelligent platform enables precise typing and treatment of diverse cancer cells.
• Paves the way for advanced diagnostic and therapeutic strategies for heterogeneous diseases.